Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabetics

Authors
Category Primary study
JournalJapan Primary Registry Network
Year 2015
INTERVENTION: Intervention type:DRUG. Intervention1:Open random study, Dose form:TABLET, Route of administration:ORAL, intended dose regimen:Teneligliptin (DPP4) 20mg daily. Control intervention1:Behavioral modification of diet and/or exercise‐therapy, Dose form:TABLET, Route of administration:ORAL, Intended dose regimen:Teneligliptin (DPP4) 20mg, daily (qd). CONDITION: diabetic patient PRIMARY OUTCOME: endothelial function. Timepoint:After 4‐week treatment. SECONDARY OUTCOME: Effect on plasma glucose levels. Timepoint: After 4‐week treatment. INCLUSION CRITERIA: Diabetic patients diabetic patients with HbA1c>7.0% (NGSP)
Epistemonikos ID: ebf127722931cdbc3ef4a88cd117d35f6e8da585
First added on: Aug 23, 2024